Canada launches its first national injury support vaccine compensation program

The Vaccine Injury Support program will “provide financial support to you if it is determined that you have experienced a serious and permanent injury after receiving a Health Canada-authorized vaccine, administered in Canada on or after December 8, 2020.”

194494278_1093645017791625_5837342534562183035_n
Share on facebook
Share on twitter
Share on linkedin
Share on reddit
Share on email

The Vaccine Injury Support program that was first announced in December 2020 by Dr. Theresa Tam, was just launched on Tuesday, June 1, 2021. The program allows for Canadians who have experienced “severe adverse reactions to an approved COVID-19 vaccine to apply for compensation”.

In the roll out of the program, Health Canada said,

 “Only vaccines that are proven to be safe, effective and of high quality are approved for use in Canada. As with all vaccines and any medication, there’s a chance that there will be a serious side effect. These are rare, but they do happen.”

The financial support will also be available to the dependents of those who have passed away after having received a vaccine, according to the Public Health Agency of Canada (PHAC). 

The financial support may include income replacement, payment for injuries, death benefits (including funeral expenses), and uncovered medical expenses. 

The compensation will be provided to claimants on a case-by-case basis. The new program will also cover all current and future Health Canada authorized vaccines. 

According to CTV News, as of May 21, there have been 5,989 reports of adverse events in Canada following a COVID-19 vaccine. 

Learn more about the program here and here.

Support Quality Journalism.

Independent journalism is important now more than ever. The role of journalists in our society is one of watchdogs. One cannot be a watchdog when they are on the government’s payroll. 

Make a donation today and support quality,  independent journalism. 

Share this story:

Share on facebook
Share on twitter
Share on email